BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26351036)

  • 41. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
    Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
    Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.
    Preibsch H; Richter V; Bahrs SD; Hattermann V; Wietek BM; Bier G; Kloth C; Blumenstock G; Hahn M; Staebler A; Nikolaou K; Wiesinger B
    Eur J Radiol; 2017 May; 90():181-187. PubMed ID: 28583631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mammographic breast density and breast cancer risk in a Mediterranean population: a nested case-control study in the EPIC Florence cohort.
    Masala G; Ambrogetti D; Assedi M; Bendinelli B; Caini S; Palli D
    Breast Cancer Res Treat; 2017 Jul; 164(2):467-473. PubMed ID: 28478611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Background parenchymal enhancement over exam time in patients with and without breast cancer.
    Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
    J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status.
    Goodburn R; Kousi E; Sanders C; Macdonald A; Scurr E; Bunce C; Khabra K; Reddy M; Wilkinson L; O'Flynn E; Allen S; Schmidt MA
    Eur Radiol; 2023 Sep; 33(9):6204-6212. PubMed ID: 37017702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.
    Lim Y; Ko ES; Han BK; Ko EY; Choi JS; Lee JE; Lee SK
    Breast Cancer Res Treat; 2017 Jun; 163(3):573-586. PubMed ID: 28349273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
    Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
    Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
    King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
    Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    Vreemann S; Gubern-Mérida A; Borelli C; Bult P; Karssemeijer N; Mann RM
    PLoS One; 2018; 13(1):e0191399. PubMed ID: 29351560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.
    Zeng L; Lo G; Moshonov H; Liang J; Hodgson D; Crystal P
    Acad Radiol; 2016 Feb; 23(2):168-75. PubMed ID: 26546383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Agreement of mammographic measures of volumetric breast density to MRI.
    Wang J; Azziz A; Fan B; Malkov S; Klifa C; Newitt D; Yitta S; Hylton N; Kerlikowske K; Shepherd JA
    PLoS One; 2013; 8(12):e81653. PubMed ID: 24324712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imperfect correlation of mammographic and clinical breast tissue density.
    Alipour S; Bayani L; Saberi A; Alikhassi A; Hosseini L; Eslami B
    Asian Pac J Cancer Prev; 2013; 14(6):3685-8. PubMed ID: 23886166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?
    Hansen NL; Kuhl CK; Barabasch A; Strobel K; Schrading S
    J Magn Reson Imaging; 2014 Aug; 40(2):483-9. PubMed ID: 24446230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fully Automated Convolutional Neural Network Method for Quantification of Breast MRI Fibroglandular Tissue and Background Parenchymal Enhancement.
    Ha R; Chang P; Mema E; Mutasa S; Karcich J; Wynn RT; Liu MZ; Jambawalikar S
    J Digit Imaging; 2019 Feb; 32(1):141-147. PubMed ID: 30076489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
    Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
    Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?
    Starikov A; Drotman M; Hentel K; Katzen J; Min RJ; Arleo EK
    Clin Imaging; 2016; 40(1):68-71. PubMed ID: 26549432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Diao P; Nielsen MB; Uldall WY; Vejborg I
    BMC Cancer; 2015 Apr; 15():274. PubMed ID: 25884160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Background Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI: Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer.
    Öztürk M; Polat AV; Süllü Y; Tomak L; Polat AK
    J Breast Health; 2017 Jan; 13(1):27-33. PubMed ID: 28331765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.